feed,title,long_url,short_url
Benzinga,"FDA Adcomm Backs AstraZeneca's 2-In-1 Asthma Inhaler, Only For Adults Being Less Sure For Adolescents, Kids",https://benzinga.com/news/large-cap/22/11/29639387/fda-adcomm-backs-astrazenecas-2-in-1-asthma-inhaler-only-for-adults-being-less-sure-for-adolescent,https://bit.ly/3DQuEF3
